OIA
BMRN icon

OneDigital Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

OneDigital Investment Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,121
Closed -$337K – 1408
2024
Q4 		$337K Buy
5,121
+43
+0.8% +$2.88K ﹤0.01% 1074
2024
Q3 		$357K Sell
5,078
-1,507
-23% -$126K ﹤0.01% 1078
2024
Q2 		$542K Buy
6,585
+970
+17% +$80.8K 0.01% 868
2024
Q1 		$490K Sell
5,615
-96
-2% -$8.59K 0.01% 746
2023
Q4 		$551K Buy
5,711
+357
+7% +$31.6K 0.01% 678
2023
Q3 		$474K Buy
5,354
+119
+2% +$10.6K 0.01% 664
2023
Q2 		$454K Buy
5,235
+26
+0.5% +$2.45K 0.01% 673
2023
Q1 		$507K Buy
5,209
+267
+5% +$27.7K 0.01% 616
2022
Q4 		$511K Buy
4,942
+7
+0.1% +$657 0.01% 516
2022
Q3 		$418K Hold
4,935
– – 0.02% 513
2022
Q2 		$409K Sell
4,935
-289
-6% -$23K 0.02% 478
2022
Q1 		$403K Sell
5,224
-1,232
-19% -$103K 0.02% 507
2021
Q4 		$570K Hold
6,456
– – 0.02% 413
2021
Q3 		$499K Sell
6,456
-19
-0.3% -$1.5K 0.02% 416
2021
Q2 		$540K Buy
6,475
+19
+0.3% +$1.51K 0.02% 390
2021
Q1 		$487K Buy
+6,456
New +$527K 0.02% 386
2019
Q3 		– Sell
-275
Closed -$24K – 625
2019
Q2 		$24K Sell
275
-10
-4% -$855 ﹤0.01% 751
2019
Q1 		$25K Sell
285
-5
-2% -$463 ﹤0.01% 665
2018
Q4 		$25K Sell
290
-220
-43% -$20.9K ﹤0.01% 625
2018
Q3 		$49K Sell
510
-115
-18% -$11.5K 0.01% 417
2018
Q2 		$59K Buy
625
+5
+0.8% +$438 0.01% 446
2018
Q1 		$50K Hold
620
– – 0.01% 515
2017
Q4 		$55K Sell
620
-10
-2% -$870 0.01% 477
2017
Q3 		$59K Hold
630
– – 0.02% 343
2017
Q2 		$57K Buy
+630
New +$57.3K 0.02% 432

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OneDigital Investment Advisors's BMRN Position: Q1 2025 in Review

OneDigital Investment Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2025, closing a stake of 5,121 shares — an estimated $337K sold.

OneDigital Investment Advisors first reported a position in BMRN in Q2 2017 and held it in 25 quarters. The position peaked at $570K in Q4 2021. 585 funds tracked by Wall St. Rank hold BMRN as of Q1 2025.

  • OneDigital Investment Advisors reported no remaining BioMarin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • OneDigital Investment Advisors sold 5,121 BioMarin Pharmaceuticals shares in Q1 2025, an estimated $337K.
  • OneDigital Investment Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2017 and held it in 25 quarters.
  • OneDigital Investment Advisors's BioMarin Pharmaceuticals position peaked at $570K in Q4 2021.
  • 585 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2025.

Based on OneDigital Investment Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.